Agenda
9:00–9:30 AM - Registration and Breakfast
9:30–9:45 AM - Welcome
Jason Schuman, PhD, Senior Product Specialist, GE Healthcare, Marlborough, MA
9:45–10:20 AM
Scope and limits of CFCA in drug discovery research
Kalyani Mondal, PhD, Scientist II, Antibody Discovery, NGM Biopharmaceuticals Inc, South San Francisco, CA
10:20–10:55 AM
Global SPR Trends: Novel QC Applications and SPR Validation Guideline Review
Fredrik Sundberg, Global Director, Strategic Customer Relations, GE Healthcare, Uppsala, Sweden
10:55–11:30 AM
Valuable Insight into your molecular interactions: New software for Biacore systems
Andrew Hill, PhD, Biacore Field Application Scientist, GE Healthcare, Marlborough, MA
11:30–12:45 PM - Lunch
12:45–1:30 PM
Data discussion session: Good, Bad, or Ugly?
Biacore team